Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

Online
ISSN
1437-4331
See all formats and pricing
Volume 41, Issue 9 (Sep 2003)

Issues

Obesity, Glucose Intolerance and Diabetes and Their Links to Cardiovascular Disease. Implications for Laboratory Medicine

Marek H. Dominiczak
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2003.194

Abstract

This article provides an overview of the role of metabolite toxicity, low-grade inflammation and disturbed cellular signaling in obesity, glucose intolerance and diabetes. It also highlights links between this continuum of deteriorating glucose tolerance and atherosclerosis.

Obesity, diabetes mellitus, and cardiovascular disease are all related to diet and to the level of physical activity. They have reached epidemic proportions worldwide. Glucose intolerance and diabetes increase the risk of atherosclerotic events. Moreover, obesity, and glucose intolerance or diabetes, are components of the metabolic syndrome, which also imparts an increased cardiovascular risk. There is increasing recognition that common mechanisms contribute to diabetes and cardiovascular disease. Following increased calorie intake and/or decreased physical activity, fuel metabolism generates excess of ‘toxic’ metabolites, particularly glucose and fatty acids. Homeostasis is affected by the endocrine output from the adipose tissue. Reactive oxygen species are generated, creating oxidative stress, which exerts major effects on signaling pathways, further affecting cellular metabolism and triggering low-grade inflammatory reaction.

This perspective on the diabetic syndrome has been reflected in the approach to its treatment, which integrates maintenance of glycemic control with primary and secondary cardiovascular prevention. Laboratory medicine should support diabetes care with an integrated package of tests which, in addition to glycemic control, enable assessment and monitoring of the risk of microvascular complications as well as cardiovascular disease.

About the article

Published Online: 2005-06-01

Published in Print: 2003-09-16


Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2003.194. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Gabriel Hoi-huen Chan, Betty Yuen-kwan Law, John Man-tak Chu, Kevin Kin-man Yue, Zhi-hong Jiang, Chi-wai Lau, Yu Huang, Shun-wan Chan, Patrick Ying-kit Yue, and Ricky Ngok-shun Wong
Evidence-Based Complementary and Alternative Medicine, 2013, Volume 2013, Page 1
[2]
R. Roman-Ramos, J. C. Almanza-Perez, A. Fortis-Barrera, S. Angeles-Mejia, T. R. Banderas-Dorantes, A. Zamilpa-Alvarez, M. Diaz-Flores, I. Jasso, G. Blancas-Flores, J. Gomez, and F. J. Alarcon-Aguilar
The American Journal of Chinese Medicine, 2012, Volume 40, Number 01, Page 97
[4]
M. Nangaku, Y. Izuhara, N. Usuda, R. Inagi, T. Shibata, S. Sugiyama, K. Kurokawa, C. van Ypersele de Strihou, and T. Miyata
Nephrology Dialysis Transplantation, 2005, Volume 20, Number 12, Page 2661
[6]
F.J. Alarcon-Aguilar, A. Fortis-Barrera, S. Angeles-Mejia, T.R. Banderas-Dorantes, E.I. Jasso-Villagomez, J.C. Almanza-Perez, G. Blancas-Flores, A. Zamilpa, M. Diaz-Flores, and R. Roman-Ramos
Journal of Ethnopharmacology, 2010, Volume 132, Number 2, Page 400
[7]
Yu-Ching Chen, Shin-Da Lee, Shin-Ying Hsih, Yung-Pei Hsu, Chia-Hua Kuo, and Low-Tone Ho
Journal of Physiology and Biochemistry, 2011, Volume 67, Number 3, Page 297
[8]
Mary M. Kimberly, Gerald R. Cooper, and Gary L. Myers
Diabetes Technology & Therapeutics, 2006, Volume 8, Number 1, Page 37
[9]
Julie Robitaille, Louis Pérusse, Claude Bouchard, and Marie-Claude Vohl
Obesity, 2007, Volume 15, Number 9, Page 2336
[13]
Hakon Hakonarsson and Kari Stefansson
Drug Development Research, 2004, Volume 62, Number 2, Page 86

Comments (0)

Please log in or register to comment.
Log in